Dolby Laboratories [DLB] vs Cintas [CTAS] Detailed Stock Comparison

Dolby Laboratories Inc.

NYSE
Loading...

Cintas Corporation

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Dolby Laboratories Inc. wins in 10 metrics, Cintas Corporation wins in 11 metrics, with 0 ties. Cintas Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dolby Laboratories Inc. Cintas Corporation Better
P/E Ratio (TTM) 26.28 36.93 Dolby Laboratories Inc.
Price-to-Book Ratio 2.39 14.59 Dolby Laboratories Inc.
Debt-to-Equity Ratio 1.56 60.94 Dolby Laboratories Inc.
PEG Ratio -1.24 3.83 Cintas Corporation
EV/EBITDA 15.70 25.01 Dolby Laboratories Inc.
Profit Margin (TTM) 17.97% 17.57% Dolby Laboratories Inc.
Operating Margin (TTM) 20.95% 23.22% Cintas Corporation
EBITDA Margin (TTM) 20.95% 23.22% Cintas Corporation
Return on Equity 9.46% 41.30% Cintas Corporation
Return on Assets (TTM) 5.26% 15.94% Cintas Corporation
Free Cash Flow (TTM) $430.26M $1.76B Cintas Corporation
Dividend Yield 2.07% 1.10% Dolby Laboratories Inc.
1-Year Return -24.85% -24.39% Cintas Corporation
Price-to-Sales Ratio (TTM) 4.63 6.34 Dolby Laboratories Inc.
Enterprise Value $5.61B $72.61B Cintas Corporation
EV/Revenue Ratio 4.19 6.59 Dolby Laboratories Inc.
Gross Profit Margin (TTM) 87.54% 50.98% Dolby Laboratories Inc.
Revenue per Share (TTM) $14 $27 Cintas Corporation
Earnings per Share (Diluted) $2.47 $4.73 Cintas Corporation
Beta (Stock Volatility) 0.86 1.01 Dolby Laboratories Inc.
Short % of Float 8.57% 3.33% Cintas Corporation

Dolby Laboratories Inc. vs Cintas Corporation Stock Performance Analysis

Loading Price Chart...

DLB
CTAS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dolby Laboratories Inc.-1.29%-1.38%-6.03%-15.21%-17.20%-13.60%
Cintas Corporation0.81%2.86%4.69%-13.31%-5.41%-5.50%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dolby Laboratories Inc.-24.85%-33.11%-42.48%16.64%22.44%147.28%
Cintas Corporation-24.39%42.25%94.50%621.09%2,070.60%1,524.86%

Performance & Financial Health Analysis: Dolby Laboratories Inc. vs Cintas Corporation

MetricDLBCTAS
Market Information
Market Cap i$6.02B$71.06B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i537,0101,878,162
90 Day Avg. Volume i611,7002,537,417
Last Close$54.89$174.72
52 Week Range$52.45 - $77.00$161.16 - $229.24
% from 52W High-28.71%-23.78%
All-Time High$104.74 (May 03, 2021)$229.24 (Jun 06, 2025)
% from All-Time High-47.59%-23.78%
Growth Metrics
Quarterly Revenue Growth-0.03%0.09%
Quarterly Earnings Growth-0.21%0.08%
Financial Health
Profit Margin (TTM) i0.18%0.18%
Operating Margin (TTM) i0.21%0.23%
Return on Equity (TTM) i0.09%0.41%
Debt to Equity (MRQ) i1.5660.94
Cash & Liquidity
Book Value per Share (MRQ)$27.15$11.97
Cash per Share (MRQ)$6.75$0.46
Operating Cash Flow (TTM) i$420.22M$2.21B
Levered Free Cash Flow (TTM) i$367.37M$1.51B
Dividends
Last 12-Month Dividend Yield i2.07%1.10%
Last 12-Month Dividend i$1.38$2.13

Valuation & Enterprise Metrics Analysis: Dolby Laboratories Inc. vs Cintas Corporation

MetricDLB (Apr 24, 2026)CTAS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i26.2836.93
Forward P/E i14.0132.20
PEG Ratio i-1.243.83
Price to Sales (TTM) i4.636.34
Price to Book (MRQ) i2.3914.59
Market Capitalization
Market Capitalization i$6.02B$71.06B
Enterprise Value i$5.61B$72.61B
Enterprise Value Metrics
Enterprise to Revenue i4.196.59
Enterprise to EBITDA i15.7025.01
Risk & Other Metrics
Beta i0.861.01
Book Value per Share (MRQ) i$27.15$11.97

Financial Statements Comparison: Dolby Laboratories Inc. vs Cintas Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDLB (2025)CTAS (2025)
Revenue/Sales i1.35B10.34B
Cost of Goods Sold i160.13M5.17B
COGS % of Revenue i11.9%50.0%
Gross Profit i1.19B5.17B
Gross Margin i88.1%50.0%
Research & Development i261.79MN/A
Operating Income (EBIT) i279.97M2.36B
Operating Margin i20.8%22.8%
EBITDA i393.57M2.86B
EBITDA Margin i29.2%27.7%
Pre-Tax Income i303.49M2.26B
Pre-Tax Income % of Revenue i22.5%21.9%
Income Tax i46.99M451.92M
Income Tax % of Revenue i3.5%4.4%
Net Income (Profit) i256.49M1.81B
Profit Margin i19.0%17.5%

Balance Sheet & Liquidity Metrics

MetricDLB (2025)CTAS (2025)
Cash & Equivalents i701.89M263.97M
Total Current Assets i1.39B3.44B
Total Current Assets % of Revenue i102.9%33.2%
Total Current Liabilities i437.79M1.64B
Total Current Liabilities % of Revenue i32.4%15.9%
Long-Term Debt i28.49M2.60B
Long-Term Debt % of Revenue i2.1%25.2%
Total Shareholders Equity i2.63B4.68B
Retained Earnings i2.63B11.80B
Retained Earnings % of Revenue i195.3%114.1%
Property, Plant & Equipment i267.63M3.50B

Cash Flow Statement Comparison

MetricDLB (2025)CTAS (2025)
Operating Cash Flow i432.40M2.27B
Operating Cash Flow % of Revenue i32.1%22.0%
Capital Expenditures i-36.35M23.97M
Free Cash Flow i430.26M1.76B
FCF Margin i31.9%17.0%
Debt Repayment iN/A-450.00M
Common Stock Repurchase i-162.23M-934.80M

Short Interest & Institutional Ownership Analysis

MetricDLBCTAS
Shares Short i3.91M9.98M
Short Ratio i6.023.80
Short % of Float i8.57%3.33%
Shares Outstanding i95.53M400.02M
Float Shares i60.20M342.08M
% Held by Insiders i1.28%14.97%
% Held by Institutions i99.28%67.80%
% Held by Public i-0.56%17.23%

Dividend Analysis & Yield Comparison: Dolby Laboratories Inc. vs Cintas Corporation

MetricDLBCTAS
Last 12-Month Dividend i$1.38$2.13
Last 12-Month Dividend Yield i2.07%1.10%
3-Year Avg Annual Dividend i$1.26$1.62
3-Year Avg Dividend Yield i0.41%0.22%
3-Year Total Dividends i$3.78$4.85
Ex-Dividend DateFeb 10, 2026Feb 13, 2026